(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.


Figure 5


Fig. 5. Cytosol immunodepleted of PKC{zeta} does not support PCTV budding but does support protein-vesicle budding. (A) PCTVs were budded from ER using native cytosol and ER treated with IgG (NC), cytosol immunodepleted of PKC{zeta} (–PKC{zeta}), or cytosol immunodepleted of PKC{zeta} to which either 2.5 µg recombinant PKC{zeta} (+rPKC{zeta}) or 2.5 µg PKC{alpha} (+rPKC{alpha}) was added. For NC, ER treated with 10 mM HEPES, pH 7.2 was used. When PKC{zeta}-depleted cytosol was used, the accompanying ER was treated with 2 M urea. Data are the mean ± s.e.m., n=4. P values indicate differences between the means of –PKC{zeta} and NC or +rPKC{zeta}, or the difference between +rPKC{alpha} and NC or +rPKC{zeta}. (B) PCTV and protein vesicles were budded from [14C]TAG and [3H]protein loaded ER using cytosol treated with IgG (NC) or cytosol immunodepleted of PKC{zeta} (–PKC{zeta}). After incubation (Materials and Methods), PCTV and protein vesicles were separated on a continuous sucrose gradient. The gradient was resolved into 20 fractions of 0.5 ml each. The first three fractions were considered to be PCTV and fractions 8 to 10 were considered to be protein vesicles. The TAG was extracted from the PCTV-containing fractions and the proteins collected from the protein-vesicle fractions after TCA precipitation. PCTV-budding activity is shown on the left and protein-vesicle budding activity on the right.